Companies in #Late-Stage Biopharma

Oberland Capital is a healthcare-focused investment firm providing structured capital to commercial-stage and late-stage clinical biopharma companies. In 2026 it announced up to $400M in financing to MeiraGTx to support eye gene therapy commercialization.